Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System® for the treatment of hepatocellular carcinoma.

about

Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System® for the treatment of hepatocellular carcinoma.

Item

http://www.wikidata.org/entity/Q41592391

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Short-term imaging response af ...... t of hepatocellular carcinoma.

@en

type

Item

label

Short-term imaging response af ...... t of hepatocellular carcinoma.

@en

prefLabel

Short-term imaging response af ...... t of hepatocellular carcinoma.

@en

P1476

Short-term imaging response af ...... nt of hepatocellular carcinoma

@en

P2093

Danielle DeMulder

http://www.w3.org/2001/XMLSchema#string

George Emmett Lynskey

http://www.w3.org/2001/XMLSchema#string

James B Spies

http://www.w3.org/2001/XMLSchema#string

Pranay Krishnan

http://www.w3.org/2001/XMLSchema#string

Shelby Frantz

http://www.w3.org/2001/XMLSchema#string

Theresa Caridi

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

Gemcitabine and liposomal doxorubicin in biliary and hepatic carcinoma (HCC) chemotherapy: preliminary results and review of the literature.

Review on transarterial chemoembolization in hepatocellular carcinoma: palliative, combined, neoadjuvant, bridging, and symptomatic indications.

Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study.

Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma.

Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort.

Quantification and reduction of reflux during embolotherapy using an antireflux catheter and tantalum microspheres: ex vivo analysis.

Chemoembolization endpoints: effect on survival among patients with hepatocellular carcinoma.

P304

e0183861

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0183861

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Alexander Y Kim

P577

2017-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28863147

http://www.w3.org/2001/XMLSchema#string

P932

5580978

http://www.w3.org/2001/XMLSchema#string